Skip to main content
. 2000 Jun 1;105(11):1563–1571. doi: 10.1172/JCI9711

Figure 2.

Figure 2

Concentration-dependent effects of D-t-EtDO-P4 on kidney, liver, and spleen glucosylceramide levels in C57BL/6 mice. The glucosylceramide synthase inhibitor was administered in a DOPC liposomal complex every 12 hours for 3 days. Mice were sacrificed 12 hours after the sixth injection (n = 3 for each time point).